Reid G. Adler

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Reid G. Adler:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vistagen Therapeutics, Inc. Chief Legal Officer Common Stock 24,050 $40,885 $1.70 30 Jun 2025 Direct
Vistagen Therapeutics, Inc. Chief Legal Officer Stock Option (Right to Buy) 100,000 23 Jun 2025 Direct

Insider Reports Filed by Reid G. Adler

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VTGN Vistagen Therapeutics, Inc. 30 Jun 2025 1 +$12,820 4 Chief Legal Officer 01 Jul 2025, 17:50
VTGN Vistagen Therapeutics, Inc. 23 Jun 2025 1 $0 4 Chief Legal Officer 25 Jun 2025, 17:15
VTGN Vistagen Therapeutics, Inc. 28 Jun 2024 1 +$14,358 4 CHF CORP DEVEL OFF, GEN COUNS 02 Jul 2024, 18:07
VTGN Vistagen Therapeutics, Inc. 24 Jun 2024 1 $0 4 CHF CORP DEVEL OFF, GEN COUNS 26 Jun 2024, 21:30
VTGN Vistagen Therapeutics, Inc. 29 Dec 2023 1 +$287 4 CHF CORP DEVEL OFF, GEN COUNS 03 Jan 2024, 17:19
VTGN Vistagen Therapeutics, Inc. 30 Jun 2023 1 +$265 4 CHIEF LEGAL OFFICER 05 Jul 2023, 16:05
VTGN VistaGen Therapeutics, Inc. 17 Aug 2022 1 +$50,910 4 CHIEF LEGAL OFFICER 19 Aug 2022, 15:45
VTGN VistaGen Therapeutics, Inc. 02 May 2022 1 $0 4 CHIEF LEGAL OFFICER 03 May 2022, 17:10
VTGN VistaGen Therapeutics, Inc. 02 May 2022 0 $0 3 CHIEF LEGAL OFFICER 03 May 2022, 17:07